VTRO — Vitro Biopharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareMicro Cap

Annual balance sheet for Vitro Biopharma, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2014 October 31st	2015 October 31st	2020 October 31st	2021 October 31st	2022 October 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	PROSPECTUS	PROSPECTUS	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	0.003	0.005	0.297	3.63	0.742
Net Total Accounts Receivable
Net Total Receivables	0.022	0.015	0.152	0.127	0.074
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	0.047	0.049	0.484	4.64	2.94
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.042	0.044	0.541	0.448	0.629
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	0.106	0.116	1.03	11.1	8.57
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.27	2.49	0.553	1.42	2.54
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.27	2.5	3.65	7.67	5.74
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	-2.16	-2.38	-2.63	3.45	2.84
Total Liabilities & Shareholders' Equity	0.106	0.116	1.03	11.1	8.57
Total Common Shares Outstanding
Total Preferred Shares Outstanding